Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly-diagnosed Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07127263
What this trial is testing

Comparison of Longer-term (5 Year+) Outcomes (Survival) of Smokers, Ex-smokers, Never Smoker and Quitters

Who this might be right for
Lung Cancer - Non Small Cell Squamous
Hywel Dda Health Board 525
Testing effectiveness (Phase 2)Study completedNCT03690921
What this trial is testing

Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial

Who this might be right for
Anal Canal Squamous Cell CarcinomaStage I Anal Cancer AJCC v8Stage II Anal Cancer AJCC v8+6 more
M.D. Anderson Cancer Center 8
Large-scale testing (Phase 3)Study completedNCT02667587
What this trial is testing

An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)

Who this might be right for
Brain Neoplasms
Bristol-Myers Squibb 716
Early research (Phase 1)Looking for participantsNCT07076498
What this trial is testing

Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation

Who this might be right for
Glioma
M.D. Anderson Cancer Center 20
Early research (Phase 1)Study completedNCT01222221
What this trial is testing

Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Cancer Research UK 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT03395587
What this trial is testing

Efficiency of Vaccination with Lysate-loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Heinrich-Heine University, Duesseldorf 136
Testing effectiveness (Phase 2)Active Not RecruitingNCT03286634
What this trial is testing

ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016

Who this might be right for
Down SyndromeAcute Lymphoblastic LeukemiaChildhood Cancer
National Hospital Organization Nagoya Medical Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT06579196
What this trial is testing

Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed Advanced NSCLC and Positive PD-L1

Who this might be right for
Non-small Cell Lung Cancer
University of Nebraska 45
Early research (Phase 1)Study completedNCT00089427
What this trial is testing

IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaOligoastrocytoma
INSYS Therapeutics Inc 24
Not applicableLooking for participantsNCT05000827
What this trial is testing

Dutch National Randomized Study: PSMA-PET/CT As a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy Patients

Who this might be right for
Prostate Cancer MetastaticProstate CancerLymph Node Metastases
Canisius-Wilhelmina Hospital 706
Testing effectiveness (Phase 2)Ended earlyNCT02341495
What this trial is testing

Deferasirox, Cholecalciferol, and Azacitidine in the Treatment of Newly Diagnosed AML Patients Over 65

Who this might be right for
Acute Myeloid Leukemia
Elizabeth Henry 4
Testing effectiveness (Phase 2)Ended earlyNCT04326439
What this trial is testing

AflacLL1901 (CHOA-AML)

Who this might be right for
Acute Myeloid LeukemiaAML, Childhood
Emory University 8
Large-scale testing (Phase 3)Study completedNCT05197257
What this trial is testing

68Ga-PSMA-11 PET in Patients With Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
University of Colorado, Denver 39
Testing effectiveness (Phase 2)UnknownNCT05447195
What this trial is testing

Phase 2 Study of CAN008 in Subjects With GBM

Who this might be right for
Newly-diagnosed Glioblastoma
CANbridge Life Sciences Ltd. 117
Testing effectiveness (Phase 2)Active Not RecruitingNCT04430894
What this trial is testing

KRDI in Transplant-Eligible MM

Who this might be right for
Multiple Myeloma
Massachusetts General Hospital 50
Early research (Phase 1)Ended earlyNCT01886573
What this trial is testing

Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery

Who this might be right for
Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07740486
What this trial is testing

A Study Comparing Treatment With Teclistamab and Talquetamab Versus Daratumumab and Lenalidomide in Patients With Multiple Myeloma After Stem Cell Transplant Who Still Have Detectable Disease

Who this might be right for
Multiple Myeloma (MM)
Polish Myeloma Consortium 248
Early research (Phase 1)Study completedNCT04277442
What this trial is testing

Testing Nivolumab in Combination With Decitabine and Venetoclax in Patients With Newly Diagnosed TP53 Gene Mutated Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
National Cancer Institute (NCI) 1
Post-approval studies (Phase 4)Study completedNCT01731886
What this trial is testing

Lenalidomide and Dexamethasone With/Without Stem Cell Transplant in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Columbia University 60
Testing effectiveness (Phase 2)Looking for participantsNCT07053059
What this trial is testing

Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL)

Who this might be right for
Acute Lymphocytic Leukemia (ALL)
M.D. Anderson Cancer Center 30
Next Page